Trial Profile
Phase 1 study of SCO-101
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Oct 2018
Price :
$35
*
At a glance
- Drugs Endovion (Primary)
- Indications Cancer
- Focus Adverse reactions
- 08 Oct 2018 New trial record